Medication Assisted Treatment Waiver Training for APRNs as of March 31, 2017

Yes, please sign me up for email updates!

APNA and PCSS-MAT will be jointly providing, at no cost, the 24 hours of training required for nurses and physician assistants to obtain waivers to prescribe buprenorphine in the treatment of opioid use disorder. This page will include links to the free medication assisted waiver training for APRNs once the process has been finalized. In the meantime, please see the below information and fill out this form to receive email updates.


Current Status

(March 31, 2017) Here are updates to the three aspects of the MAT waiver process for APRNs: the required 24 hours of education, the process for issuing MAT waivers, and the regulations for implementing the CARA 2016 legislation.

  • Educational Content for Required Training
    APNA continues to work with our partners at PCSS-MAT to finalize the updated content and optimize it for continuing nursing education contact hours. We anticipate that the program will be ready during the month of April.
     
  • OMB Approval of MAT Waiver Issuance Process
    From SAMHSA Website as of February 28, 2017:

NPs and PAs who have completed the 24 hours of required training may seek to obtain a DATA 2000 waiver for up to 30 patients by completing the Waiver Notification Form. Effective February 27, 2017, SAMHSA will only accept electronic submissions of the NOI. NPs and PAs may send copies of their training certificates to infobuprenorphine@samhsa.hhs.gov or faxed them to 301-576-5237.

These waiver applications will be forwarded to the DEA, which will assign the NP or PA a special identification number. DEA regulations require this number to be included on all buprenorphine prescriptions for opioid dependency treatment, along with the NP’s or PA’s regular DEA registration number. SAMHSA shall review waiver applications within 45 days of receipt. If approved, NPs and PAs will receive a letter via email that confirms their waiver and includes their prescribing identification number.
 

  • HHS Regulation to Implement CARA 2016
    No further HHS regulation is needed before eligible NPs or PAs with a properly authorized wavier can begin prescribing buprenorphine, subject to applicable statutory patient limits.

 

Yes, please sign me up for email updates!

The American Psychiatric Nurses Association is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.